These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 21784369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An assessment of cholesterol goal attainment in patients with chronic kidney disease.
    Stadler SL, Bhardwaja B, Olson KL, Powers JD, Lanese D.
    J Clin Lipidol; 2010; 4(4):298-304. PubMed ID: 21122663
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis.
    Raggi P, Giachelli C, Bellasi A.
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):26-33. PubMed ID: 17180147
    [Abstract] [Full Text] [Related]

  • 8. [Dyslipidemia in renal failure].
    Fujioka T, Ueno T, Matsumoto T, Watanabe H.
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Gemfibrozil: new aspects in clinical use].
    Tada N.
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract] [Full Text] [Related]

  • 11. Kidney disease in cardiology.
    Herzog CA.
    Nephrol Dial Transplant; 2009 Jan; 24(1):34-7. PubMed ID: 19028753
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consensus statement for the prevention of vascular disease.
    National Vascular Disease Prevention Alliance.
    Aust Fam Physician; 2004 Apr; 33(4):235-9. PubMed ID: 15129468
    [Abstract] [Full Text] [Related]

  • 14. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
    Vogt L, Laverman GD, Dullaart RP, Navis G.
    Nephrol Dial Transplant; 2004 Jan; 19(1):5-8. PubMed ID: 14671028
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S, Rognant N, Chiche F, Cremer A, Deray G, Priou M.
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.